These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32870563)

  • 1. Catalytic Asymmetric Synthesis of the anti-COVID-19 Drug Remdesivir.
    Wang M; Zhang L; Huo X; Zhang Z; Yuan Q; Li P; Chen J; Zou Y; Wu Z; Zhang W
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20814-20819. PubMed ID: 32870563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Synthesis of the Anti-COVID-19 Drug Remdesivir.
    Wang M; Zhang L; Huo X; Zhang Z; Zhang W
    Curr Protoc; 2021 Dec; 1(12):e303. PubMed ID: 34878730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and Catalytic C-Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside.
    Obradors C; Mitschke B; Aukland MH; Leutzsch M; Grossmann O; Brunen S; Schwengers SA; List B
    Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202114619. PubMed ID: 34856043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical Remdesivir Synthesis through One-Pot Organocatalyzed Asymmetric (
    Gannedi V; Villuri BK; Reddy SN; Ku CC; Wong CH; Hung SC
    J Org Chem; 2021 Apr; 86(7):4977-4985. PubMed ID: 33634692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Application of Chiral Bicyclic Imidazole Catalysts.
    Wang M; Zhang Z; Zhang W
    Acc Chem Res; 2022 Sep; 55(18):2708-2727. PubMed ID: 36043467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanoamidine Cyclization Approach to Remdesivir's Nucleobase.
    Knapp RR; Tona V; Okada T; Sarpong R; Garg NK
    Org Lett; 2020 Nov; 22(21):8430-8435. PubMed ID: 33085486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus.
    El-Sayed NS; Jureka AS; Edwards MR; Lohan S; Williams CG; Keiser PT; Davey RA; Totonchy J; Tiwari RK; Basler CF; Parang K
    Eur J Med Chem; 2021 Dec; 226():113862. PubMed ID: 34583312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Chemoenzymatic Synthesis of the (
    Bigley AN; Narindoshvili T; Raushel FM
    Biochemistry; 2020 Aug; 59(33):3038-3043. PubMed ID: 32786401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options.
    Sreekanth Reddy O; Lai WF
    Chembiochem; 2021 Mar; 22(6):939-948. PubMed ID: 33031623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Do We Know About Remdesivir Drug Interactions?
    Yang K
    Clin Transl Sci; 2020 Sep; 13(5):842-844. PubMed ID: 32402130
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthetic Attempts Towards Eminent Anti-viral Candidates of SARS-CoV.
    Kundu S; Sarkar D
    Mini Rev Med Chem; 2022; 22(2):232-247. PubMed ID: 34254915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the molecular structure of Remdesivir for the treatment of Covid-19.
    Sheikholeslami SM; Jahanbani A; Shao Z
    Comput Methods Biomech Biomed Engin; 2021 Jul; 24(9):995-1002. PubMed ID: 33356621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir.
    Banerjee A; Kanwar M; Maiti S
    Drug Res (Stuttg); 2021 Oct; 71(8):462-472. PubMed ID: 34517419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update Alert 2: Remdesivir for Adults With COVID-19.
    Kaka AS; MacDonald R; Linskens EJ; Wilt TJ
    Ann Intern Med; 2021 Dec; 174(12):W114-W115. PubMed ID: 34606312
    [No Abstract]   [Full Text] [Related]  

  • 15. [Remdesivir, the antiviral hope against SARS-CoV-2].
    Reina J
    Rev Esp Quimioter; 2020 Jun; 33(3):176-179. PubMed ID: 32239125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.
    Jung LS; Gund TM; Narayan M
    Protein J; 2020 Dec; 39(6):619-630. PubMed ID: 33185784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2.
    Xie Y; Yin W; Zhang Y; Shang W; Wang Z; Luan X; Tian G; Aisa HA; Xu Y; Xiao G; Li J; Jiang H; Zhang S; Zhang L; Xu HE; Shen J
    Cell Res; 2021 Nov; 31(11):1212-1214. PubMed ID: 34584244
    [No Abstract]   [Full Text] [Related]  

  • 18. Off-Target
    Xu Y; Barauskas O; Kim C; Babusis D; Murakami E; Kornyeyev D; Lee G; Stepan G; Perron M; Bannister R; Schultz BE; Sakowicz R; Porter D; Cihlar T; Feng JY
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.
    Weinbergerova B; Mayer J; Kabut T; Hrabovsky S; Prochazkova J; Kral Z; Herout V; Pacasova R; Zdrazilova-Dubska L; Husa P; Bednar P; Ruzek D; Lengerova M
    Hematol Oncol; 2021 Dec; 39(5):715-720. PubMed ID: 34396566
    [No Abstract]   [Full Text] [Related]  

  • 20. The Enzyme-Free Release of Nucleotides from Phosphoramidates Depends Strongly on the Amino Acid.
    Jovanovic D; Tremmel P; Pallan PS; Egli M; Richert C
    Angew Chem Int Ed Engl; 2020 Nov; 59(45):20154-20160. PubMed ID: 32757352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.